Strategic Partnerships Dendi actively expands through partnerships with labs and healthcare providers, recent collaborations include Get Well Urgent Care, MolecularLabPartners, Adela, and Atlantic Diagnostic Laboratories, indicating strong sales opportunities through channel and integration partnerships.

Expansion Readiness New client wins and migrations to Dendi’s cloud-based LIS from legacy systems suggest a market momentum for converting multi-location and POLs to Dendi, presenting upsell potential for larger lab networks and urgent care chains.

HighVolume & Novel Testing Dendi supports diverse modalities (blood, toxicology, molecular, genomics, esoteric testing), signaling opportunities to cross-sell to labs expanding into specialized and high-complexity testing workflows.

Implementation Speed In-house integrations team emphasizes rapid interface setup with instruments, EMRs, and billing providers, a compelling differentiator for labs seeking quick modernization and turnkey LIS deployments.

Financial Scale With a revenue band of 50–100 million and a recent $2M investment, Dendi demonstrates credible financial health and growth trajectory, suggesting fundraising-backed expansion into new markets and higher-value enterprise deals.